Navigation Links
Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
Date:11/1/2007

in survival over time. "We wanted to understand if the new therapies available to these patients would translate directly into improved survival," said lead author Shaji Kumar, MD, of the Mayo Clinic.

The first analysis studied 387 patient records to compare disease relapses before and after December 31, 2000, based on the availability of thalidomide and subsequent clinical trials of bortezomib and lenalidomide. The second analysis was conducted over a 36-year period (1971-2006) with a larger group of 2,981 patients with newly diagnosed MM. These patients were divided by date of diagnosis (before or after January 1, 1997) to understand the significance of the novel advances in MM therapies.

Study results illustrated a dramatic improvement in survival among patients diagnosed in recent years, both from the time of diagnosis and from relapse after stem cell transplantation. Among the patients in the relapse group, the researchers noted a significant improvement in overall survival for patients relapsing after 2000, compared with those relapsing before 2000 (24 vs. 12 months). Patients relapsing before 2000 were less likely to receive a prompt transplant and more likely to have relapsed disease at the time of transplant and to have had more treatment regimens prior to transplant, compared with the group who relapsed after 2000, but the improvement seen in the recent times was independent of these differences.

In the larger group of newly diagnosed MM patients, diagnosis within the last decade translated into a 50 percent improvement in overall survival (45 vs. 30 months). Though the team divided the groups into six-year intervals to understand trends throughout the 36 years, they found no significant changes in survival until the most recent six-year period. When the team examined the relative impact of age and gender, they found that patients younger than 65 benefited the most from the recent improvements and that female patients fared slightly be
'/>"/>

SOURCE American Society of Hematology
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
4. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
5. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
10. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
11. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... SYDNEY , May 16, 2013  HeartWare International, Inc. ... innovator of less invasive, miniaturized circulatory support technologies that are ... CEO Doug Godshall is scheduled to ... a.m. EDT on Monday, May 20, 2013.  The conference is ... Hotel. A live webcast of the Company,s presentation ...
(Date:5/16/2013)... , May 16, 2013  Amgen (NASDAQ: AMGN ... on Tuesday, May 21, 2013, at the Sheraton New York ... beginning at 10:00 a.m. Eastern Daylight Time. Joseph ... Research and Development at Amgen, will present at the conference. ... Events Calendar on Amgen,s website, www.amgen.com , under Investors. ...
(Date:5/16/2013)... , May 16, 2013 ... in the U.S. to access the widely-used OrthoView digital ... PC and Internet connection to get started. ... software for over 10 years, is dedicated to enabling ... with digital x-ray images, when printed film is unavailable. ...
Breaking Medicine Technology:HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
... 2011 Sharp HealthCare,s affiliated medical groups -- Sharp ... Elite Status, the highest possible designation for quality care ... as part of its 2011 Standards of Excellence program. ... of managed care physician groups. "We are ...
... Healthcare Partners , a strategic private equity firm focused ... it has completed a sale and recapitalization of CareCentrix, ... is the nation,s leading provider of home health benefits ... sold its majority interest in CareCentrix to Summit Partners. ...
Cached Medicine Technology:Sharp HealthCare Medical Groups Recognized for "Elite" Care 2Sharp HealthCare Medical Groups Recognized for "Elite" Care 3Water Street Healthcare Partners Completes Sale and Recapitalization of CareCentrix 2Water Street Healthcare Partners Completes Sale and Recapitalization of CareCentrix 3
(Date:5/19/2013)... everywhere have long recognized ginger as a great way ... and savory dishes; now, a study from researchers at ... also may have properties that help asthma patients breathe ... be presented at the ATS 2013 International Conference. , ... bronchial tubes that carry air into and out of ...
(Date:5/19/2013)... 19, 2013 In partnership with the medical ... announced the launch of an SEO website for dentists. The ... rankings in Google. , http://www.e-dentists.com/ , A perk ... the service until they see results. Dentists can request the ... websites run by JD Media Surge, LLC rank high for ...
(Date:5/19/2013)... According to a new market research ... – 2018): By Applications (Healthcare (Endoscopy, Radiology, Ophthalmology), ... Contact IS, Infrared, X-Ray) And Geography" published by ... $8.00 billion in 2012 and is expected to ... CAGR of 3.84% from 2013 to 2018. In ...
(Date:5/19/2013)... New York, New York (PRWEB) May 19, 2013 ... note that a Case Management Conference was recently convened ... in a federal multidistrict litigation now underway in U.S. ... Minutes posted on the Court’s website on May 14th, ... motions. It was also reported during the Conference ...
(Date:5/19/2013)... Vegas, Nevada (PRWEB) May 19, 2013 ... agency , is proud to announce the launch it's ... Awards at the MGM Grand on 5/19/2013. Consumers traveling ... all new special pricing available on VegasHotelEscapes.com's website. Travelers ... that they beat any competitors price. , Vegas Hotel ...
Breaking Medicine News(10 mins):Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
... Calif., Sept. 13 ,Exelixis, Inc. (Nasdaq: EXEL ) ... financial officer of Exelixis, will present at the,Bank of ... 1:00 p.m.,(ET) on Tuesday, September 18, 2007. The ... the Event,Calendar page under Investors on the Exelixis website ...
... and tasty treats, SAN DIEGO, Sept. 13 ... Fruit and Vegetable Month this September.,RealAge.com, the leading healthy-lifestyle ... healthy and just might make you feel,younger than the ... RealAge.com featured this confection in the RealAge Tip of ...
... is safer , , THURSDAY, Sept. 13 (HealthDay News) -- ... those coated with the medication siromilus appear to be ... , Analysis of 38 trials involving more than 18,000 ... best overall profile, if you look at the entire ...
... of your level of,expertise, you will have a lot to ... Do you know: The essential DNA for quality ... How to exploit process and quality for competitive advantage? ... How to achieve product innovation excellence? The benefits ...
... VILLAGE, Calif., Sept. 13 Hackensack,University Medical ... located,in Hackensack, N.J., and affiliated with The ... Jersey Medical School, is the first hospital ... experience in all,four service areas: inpatient, outpatient, ...
... and Standard,Options, WASHINGTON, Sept. 13 Federal ... from the Blue Cross,and Blue Shield Association,s (BCBSA) ... in 2008., FEP health premiums remain very ... stay essentially unchanged from last year. Federal,employees, retirees ...
Cached Medicine News:Health News:RealAge.com Suggests a Reason to Celebrate in September! 2Health News:Drug-Coated Stents Go Head to Head 2Health News:Drug-Coated Stents Go Head to Head 3Health News:Quality Innovators to Network in Atlanta Sept. 19-21: Learn from Those Who Got It Right 2Health News:J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas 2Health News:J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas 3Health News:Federal Employee Program Maintains Low Health Premiums In 2008 2Health News:Federal Employee Program Maintains Low Health Premiums In 2008 3
... Facilitates grasping and implanting the ... and within the capsular bag without ... mm long jaws are placed in ... handle. Smooth, flat, cross action handle ...
Fine 3.0 mm platformed angled 60 degrees 10 mm from angle to tip. Serrated handle with dull finish....
Puntenney curved forceps, curved, smooth 10 mm platforms....
Hatsis tying forceps, titanium, long thin tying platforms....
Medicine Products: